1.Szczech LA, Anderson A, Ramers C, Engeman J, Ellis M, Butterly D, Howell DN: The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease. Am J Kidney Dis 2006, 48(4):e55–59.
2.Wyatt CM: Kidney Disease and HIV Infection. Top Antivir Med 2017, 25(1):13–16.
3.Ray PE: HIV-associated nephropathy: a diagnosis in evolution. Nephrol Dial Transplant 2012, 27(11):3969–3972.
4.Jotwani V, Atta MG, Estrella MM: Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy. J Am Soc Nephrol 2017, 28(11):3142–3154.
5.Savige JA, Chang L, Horn S, Crowe SM: Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 1994, 18(3):205–211.
6.Minocha V, Makary R, Poenariu A: An Unusual Case of Anti-GBM Antibody Elevation in HIV-Associated Nephropathy. Case Rep Nephrol 2014, 2014:956475.
7.Jia XY, Hu SY, Chen JL, Qu Z, Liu G, Cui Z, Zhao MH: The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy. Kidney Int 2014, 85(4):945–952.
8.Netzer KO, Leinonen A, Boutaud A, Borza DB, Todd P, Gunwar S, Langeveld JP, Hudson BG: The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17–31 and 127–141 of the NC1 domain. J Biol Chem 1999, 274(16):11267–11274.
9.Szczech LA: Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. Clin Infect Dis 2001, 33(1):115–119.
10.Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE et al: The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004, 66(3):1145–1152.
11.Calderon EJ, Wichmann I, Varela JM, Respaldiza N, Regordan C, Fernandez-Alonso J, Medrano FJ, Cano S, Cuello JA, Nunez-Roldan A: Presence of glomerular basement membrane (GBM) antibodies in HIV- patients with Pneumocystis carinii pneumonia. Clin Exp Immunol 1997, 107(3):448–450.
12.Lizarraga KJ, Florindez JA, Daftarian P, Andrews DM, Ortega LM, Mendoza JM, Contreras GN, Nayer A: Anti-GBM disease and ANCA during dengue infection. Clin Nephrol 2015, 83(2):104–110.
13.Kalluri R, Wilson CB, Weber M, Gunwar S, Chonko AM, Neilson EG, Hudson BG: Identification of the Alpha–3 Chain of Type-Iv Collagen as the Common Autoantigen in Antibasement Membrane Disease and Goodpasture-Syndrome. Journal of the American Society of Nephrology 1995, 6(4):1178–1185.
14.Dehan P, Weber M, Zhang X, Reeders ST, Foidart JM, K. T: Sera from patients with anti-GBM nephritis including goodpasture syndrome show heterogenous reactivity to recombinant NC1 domain of type IV collagen alpha chains. Nephrol Dial Transplant 1996, 11(11):2215–2222.
15.Cui Z, Zhao MH, Jia XY, Wang M, Hu SY, Wang SX, Yu F, Brown KL, Hudson BG, Pedchenko V: Antibodies to alpha5 chain of collagen IV are pathogenic in Goodpasture’s disease. J Autoimmun 2016, 70:1–11.
16.Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, Wang HY: Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant 2009, 24(6):1838–1844.
17.Chen L, Hellmark T, Wieslander J, Bolton WK: Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats. Kidney Int 2003, 64(6):2108–2120.
18.J. A.Savige, L.Chang, S.Horn, S. M.Crowe: Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 1994 18(3):205–211.